Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mitchell Chan
Mitchell Chan is recorded as CFO and Chief Accounting Officer at REGENXBIO Inc. (RGNX). REGENXBIO Inc. reported in an 8-K filed September 17, 2024 that Mitchell Chan was appointed Principal Accounting Officer, effective September 16, 2024. REGENXBIO Inc. reported in an 8-K filed September 17, 2024 that Mitchell Chan was appointed Executive Vice President, Chief Financial Officer and Principal Accounting Officer, effective September 16, 2024. The proxy statement of REGENXBIO Inc. reports total compensation of $3,205,294 for Mitchell Chan in fiscal 2024, including a base salary of $141,346. Mitchell Chan has spoken on 3 earnings calls and 2 other investor events across 1 company, most recently for REGENXBIO Inc. on September 16, 2026.
“On September 16, 2024, the board of directors (the "Board" of REGENXBIO Inc. (the "Company") appointed Mitchell Chan as Executive Vice President, Chief Financial Officer and Principal Accounting Officer, effective immediately.”
REGENXBIO Inc. Form 8-K, filed September 17, 2024
· Read the filing
“On September 16, 2024, the board of directors (the "Board" of REGENXBIO Inc. (the "Company") appointed Mitchell Chan as Executive Vice President, Chief Financial Officer and Principal Accounting Officer, effective immediately.”
REGENXBIO Inc. Form 8-K, filed September 17, 2024
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
